Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,350.00
+35.00 (1.06%)
Sep 18, 2026, 3:30 PM KST

Oncocross Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
43,705115,23175,179---
Market Cap Growth
-62.35%53.27%----
Enterprise Value
27,47793,53862,376---
Last Close Price
3350.009580.006340.00---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
110.51311.0570.12---
PB Ratio
3.228.623.68---
P/TBV Ratio
3.248.653.68---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
69.47252.4958.18---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.660.400.030.010.050.20
Net Debt / Equity Ratio
-1.20-1.35-0.99-1.00-1.00-1.08
Net Debt / EBITDA Ratio
1.862.253.082.590.701.70
Net Debt / FCF Ratio
1.701.693.553.360.791.84
Asset Turnover
0.020.010.050.010.010.01
Quick Ratio
1.374.1111.3515.164.477.87
Current Ratio
1.444.2111.4215.254.597.93
Return on Equity (ROE)
-42.57%-52.79%-35.10%-36.33%-114.08%-
Return on Assets (ROA)
-24.14%-21.43%-21.69%-32.76%-53.18%-27.13%
Return on Capital Employed (ROCE)
-71.60%-38.00%-33.60%-41.30%-146.40%-55.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-14.96%-7.75%-8.62%---
FCF Yield
-21.84%-9.29%-7.56%---
Buyback Yield / Dilution
-7.59%-14.17%-17.54%-1.44%-63.74%-0.83%